Global SNP Genotyping and Analysis Market Growth (Status and Outlook) 2025-2031
The global SNP Genotyping and Analysis market size is predicted to grow from US$ 1832 million in 2025 to US$ 4804 million in 2031; it is expected to grow at a CAGR of 17.4% from 2025 to 2031.
A SNP is a single base pair mutation that occurs at a specific site in the DNA sequence. There are usually two variations, or alleles, with one occurring only in between 1% to 5% of the population. On average, two humans, DNA sequences differ in more than three million positions. In some cases, this variation results in the one minor allele causing or predisposing the individual to have a certain disease or trait. The SNP Genotyping and Analysis industry can be broken down into several segments, Dynamic Allele-Specific Hybridization, Molecular Beacons, SNP Microarrays, etc.
Global key players of SNP genotyping and analysis include Thermo Fisher Scientific, Illumina, Agilent Technologies, Roche, Bio-rad, etc. Global top five manufacturers hold a share over 87%. The key players are mainly located in Europe and North America. In terms of product, dynamic allele-Specific hybridization is the largest segment, with a share over 48%. And in terms of application, the largest application is pharmaceuticals and pharmacogenomics, with a share over 52%.
LPI (LP Information)' newest research report, the “SNP Genotyping and Analysis Industry Forecast” looks at past sales and reviews total world SNP Genotyping and Analysis sales in 2024, providing a comprehensive analysis by region and market sector of projected SNP Genotyping and Analysis sales for 2025 through 2031. With SNP Genotyping and Analysis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world SNP Genotyping and Analysis industry.
This Insight Report provides a comprehensive analysis of the global SNP Genotyping and Analysis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on SNP Genotyping and Analysis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global SNP Genotyping and Analysis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for SNP Genotyping and Analysis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global SNP Genotyping and Analysis.
This report presents a comprehensive overview, market shares, and growth opportunities of SNP Genotyping and Analysis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Dynamic Allele-Specific Hybridization
Molecular Beacons
SNP Microarrays
Segmentation by Application:
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Breeding and Animal Livestock
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
Agilent Technologies
Roche
Bio-rad
LGC
Sequenom
Beckman Coulter
QIAGEN
Fluidigm
Please note: The report will take approximately 2 business days to prepare and deliver.